This company listing is no longer active
BBS-Bioactive Bone Substitutes Oyj Balance Sheet Health
Financial Health criteria checks 2/6
Key information
132.8%
Debt to equity ratio
€5.67m
Debt
Interest coverage ratio | n/a |
Cash | €1.52m |
Equity | €4.27m |
Total liabilities | €6.42m |
Total assets | €10.69m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BONES's short term assets (€1.9M) exceed its short term liabilities (€1.7M).
Long Term Liabilities: BONES's short term assets (€1.9M) do not cover its long term liabilities (€4.7M).
Debt to Equity History and Analysis
Debt Level: BONES's net debt to equity ratio (97.3%) is considered high.
Reducing Debt: BONES's debt to equity ratio has reduced from 1598.9% to 132.8% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BONES has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: BONES has less than a year of cash runway if free cash flow continues to reduce at historical rates of 16.1% each year